The expression of PKM2 was determined to be heterogeneous even within a single tumor, but there is a lack of clinical verification of the correlation between PKM2 and chemoresistance because patients usually do not undergo surgery when they became resistant to chemotherapy in an advanced stage. This evidence concerns the gene PKM and neoplasm.